Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

Share Price is delayed by 15 minutes
Get Live Data
109.50    2.00 (1.86%)
Bid:
105.50
Ask:
106.50
Spread: 1.00 (0.948%)
Market Cap: £107.91m
ECEL Live PriceLast checked at - London Stock Exchange

Intraday Eurocell Share Chart

AGM Trading Update

19 May 2016 07:00

RNS Number : 6543Y
Eurocell plc
19 May 2016
 

19th May 2016

 

Eurocell plc

AGM Trading Update and Director Appointment

 

Eurocell plc ("Eurocell" or the "Company"), the leading sustainable B2B supplier of PVC building products with its own distribution network, today provides a trading update for the first 20 weeks of the financial year to 13th May 2016.

Eurocell has had a positive start to the year with Group revenues up 16.3% to £69.8 million. Both the Profiles and the Building Plastics divisions delivered improved revenues on last year, with like for like sales in the branch network ahead by 11.8%, although in a very competitive market. There were 7 new branches opened during the period and the Company is on track to deliver 15 new sites in the current year as a whole. Both of the recent acquisitions, S & S Plastics and Vista Panels are delivering to expectations.

The UK RMI market conditions remain stable, and benefited from relatively mild weather in January and February. We have seen some movement in resin prices through ethylene increases, this has had limited impact to date.

We are also pleased to announce the appointment of Michael Scott as Chief Financial Officer on 1st September 2016. Michael is currently Head of Corporate Finance at Drax Group plc. He has been with Drax since 2005, having previously held the positions of Head of Investor Relations and Group Financial Controller. Michael also served as Interim Group Finance Director between May and December 2015. Prior to joining Drax, he worked for MT International and Arthur Andersen, where he qualified as a Chartered Accountant.

The half year results will be announced on 23 August 2016.

 

Bob Lawson, Chairman of Eurocell, commented:

"Eurocell has had a positive start to the year. We are delighted with today's appointment of Michael as CFO. He will bring considerable relevant experience particularly given his recent finance and IR roles at Drax. Alongside Mark, who is already making a positive impact as CEO, we have the right management team to further develop Eurocell from the strong platform they inherit. Overall, the business is positioned well and I am confident about our prospects for the future."

 

There are no further disclosures to be made on the appointment of Michael Scott pursuant to 9.6.13 of the Listing Rules

 

Further Enquiries:

Ben Foster, Camilla Cunningham 020 3603 5221

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCAPMFTMBMBBBF
Date   Source Headline
16th Mar 20237:00 amRNSPreliminary results for the year ended 31 Dec 2022
7th Mar 20237:00 amRNSBlock listing Interim Review
3rd Feb 20237:00 amRNSNon-executive Directors' Share Purchase Plan
31st Jan 20237:00 amRNSHolding(s) in Company
26th Jan 20237:00 amRNSYear End Trading Update
6th Jan 20237:00 amRNSCEO Announces Intention to Retire in 2023
15th Nov 20227:04 amRNSHolding(s) in Company
14th Nov 20227:00 amRNSHolding(s) in Company
10th Nov 20224:00 pmRNSHolding(s) in Company
8th Nov 20223:59 pmRNSDirectorate Change
26th Oct 20227:00 amRNSHolding(s) in Company
7th Oct 20227:00 amRNSChanges to Board Committee memberships
5th Oct 20222:00 pmRNSHolding(s) in Company
3rd Oct 20227:00 amRNSTotal Voting Rights
5th Sep 20227:00 amRNSBlock listing Interim Review
5th Sep 20227:00 amRNSInvestor Presentation
1st Sep 20227:00 amRNSHalf-year Report
15th Aug 20223:00 pmRNSHolding(s) in Company
10th Aug 20223:45 pmRNSAppointment to the Audit & Risk Committee
13th Jul 20227:00 amRNSTrading Update
5th Jul 202212:25 pmRNSHolding(s) in Company
1st Jul 20227:00 amRNSTotal Voting Rights
22nd Jun 20227:00 amRNSDirector/PDMR Shareholding
21st Jun 202212:08 pmRNSDirectorate Change
25th May 20227:00 amRNSBlock Listing Application
16th May 20227:00 amRNSDirector/PDMR Shareholding
12th May 20224:00 pmRNSResult of AGM
12th May 20227:00 amRNSAGM Trading Update and Board Update
14th Apr 20224:00 pmRNSDirector/PDMR Shareholding
14th Apr 20224:00 pmRNSDirector/PDMR Shareholding
8th Apr 20227:00 amRNSAnnual Financial Report
21st Mar 20227:00 amRNSInvestor Presentation
18th Mar 20227:00 amRNSPreliminary results for the year ended 31 Dec 2021
17th Mar 20227:00 amRNSNotice of Results and Audiocast
15th Mar 20223:05 pmRNSTransaction in Own Shares
9th Mar 20225:00 pmRNSBlock listing Interim Review
16th Feb 20227:00 amRNSAppointment of Joint Corporate Broker
21st Jan 20227:00 amRNSYear End Trading Update
4th Jan 20227:00 amRNSTotal Voting Rights
1st Dec 20217:00 amRNSTotal Voting Rights
24th Nov 20217:00 amRNSTrading Update November 2021
1st Nov 20217:00 amRNSTotal Voting Rights
1st Oct 20217:00 amRNSTotal Voting Rights
7th Sep 20214:00 pmRNSInvestor Presentation
7th Sep 20211:38 pmRNSBlock listing Interim Review
3rd Sep 20217:00 amRNSHalf-year Report
1st Sep 20217:00 amRNSTotal Voting Rights
2nd Aug 20217:00 amRNSTotal Voting Rights
20th Jul 20217:00 amRNSTrading Update
1st Jul 20217:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.